What’s more, since increased H3K4me3 might interact with DNMT3A-DNMT3L (Du et al., 2015), the crosstalk between histone modification and DNA methylation may have collaborative effects on cysteine metabolism in trastuzumab primary-resistant breast cancer. The gene discussed is DNMT3A; the disease is breast carcinoma.